Percutaneous radiofrequency ablation for small hepatocellular carcinoma in hepatic dome under MR-guidance: clinical safety and efficacy

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Seror O, N’Kontchou G, Nault JC, et al. Hepatocellular carcinoma within milan criteria: no-touch multibipolar radiofrequency ablation for treatment-long-term results. Radiology. 2016;280(2):611–621.
   PubMed Web of Science ®Google Scholar
• Dong Ho L, Jeong Min L, Jae Young L, et al. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology. 2014;270(3):900–909.
   PubMed Web of Science ®Google Scholar
• Xu XL, Liu XD, Liang M, et al. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: systematic review of randomized controlled trials with meta-analysis and trial sequential analysis. Radiology. 2017;287:461–472.
   PubMed Web of Science ®Google Scholar
• Alessandro C, Fabio P, Matteo C, et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol. 2013;59(2):300–307.
   PubMed Web of Science ®Google Scholar
• Kim YS, Rhim H, Sung JH, et al. Bronchobiliary fistula after radiofrequency thermal ablation of hepatic tumor. J Vasc Intervent Radiol. 2005;16(3):407–410.
   PubMed Web of Science ®Google Scholar
• Li M ,Yu XL ,Liang P, et al. Percutaneous microwave ablation for liver cancer adjacent to the diaphragm. Int J Hyperthermia. 2012;28(3):218–226.
   PubMed Web of Science ®Google Scholar
• Asvadi NH, Anvari A, Uppot RN, et al. CT-guided percutaneous microwave ablation of tumors in the hepatic dome: assessment of efficacy and safety. J Vasc Intervent Radiol. 2016;27(4):496–502.
   PubMed Web of Science ®Google Scholar
• Yu NC, Chaudhari V, Raman SS, et al. CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol H. 2011;9(2):161–167.
   PubMed Web of Science ®Google Scholar
• Stephan C, Pereira PL. Magnetic resonance guidance for radiofrequency ablation of liver tumors. J Magn Reson Imaging. 2010;27(2):421–433.
   Web of Science ®Google Scholar
• Hoffmann R, Rempp H, Kessler DE, et al. MR-guided microwave ablation in hepatic tumours: initial results in clinical routine. Eur Radiol. 2017;27(4):1467–1476.
   PubMed Web of Science ®Google Scholar
• Terraz S, Cernicanu A, Lepetit-Coiffé M, et al. Radiofrequency ablation of small liver malignancies under magnetic resonance guidance: progress in targeting and preliminary observations with temperature monitoring. Eur Radiol. 2010;20(4):886–897.
   PubMed Web of Science ®Google Scholar
• Rempp H, Waibel L, Hoffmann R, et al. MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions. Eur Radiol. 2012;22(9):1972–1982.
   PubMed Web of Science ®Google Scholar
• Medical and Health Care Bureau of the Health and Family Planning Commission of the People’s Republic of China. Criteria for diagnosis and treatment of primary liver cancer (2017 edition). Inform Infect Dis. 2017;16:705–720.
   Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria – a 10-year update: supplement to the consensus document. Radiology. 2014;273(1):241–260.
   PubMed Web of Science ®Google Scholar
• Tito L, Luigi S, M Franca M, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226(2):441–451.
   PubMed Web of Science ®Google Scholar
• Song KD, Lee MW, Rhim H, et al. Percutaneous US/MRI fusion-guided radiofrequency ablation for recurrent subcentimeter hepatocellular carcinoma: technical feasibility and therapeutic outcomes. Radiology. 2018;288:878–886.
   PubMed Web of Science ®Google Scholar
• Lee MW, Rhim H, Cha DI, et al. Planning US for percutaneous radiofrequency ablation of small hepatocellular carcinomas (1–3 cm): value of fusion imaging with conventional US and CT/MR images. J Vasc Interv Radiol. 2013;24(7):958–965.
   PubMed Web of Science ®Google Scholar
• Yu NS, Hyunchul R, Tae Wook K, et al. Percutaneous radiofrequency ablation for hepatic tumors abutting the diaphragm: clinical assessment of the heat-sink effect of artificial ascites. AJR Am J Roentgenol. 2010;194(2):227–231.
   Web of Science ®Google Scholar
• Zhang D, Liang P, Yu X, et al. The value of artificial pleural effusion for percutaneous microwave ablation of liver tumour in the hepatic dome: a retrospective case-control study. Int J Hyperther. 2013;29(7):663–670.
   PubMed Web of Science ®Google Scholar
• Tang C, Shen J, Feng W, et al. Combination therapy of radiofrequency ablation and transarterial chemoembolization for unresectable hepatocellular carcinoma: a retrospective study. Medicine. 2016;95(20):e3754.
   PubMed Web of Science ®Google Scholar
• Shibata T, Shibata T, Maetani Y, et al. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome. J Vasc Intervent Radiol. 2004;15(11):1323–1327.
   PubMed Web of Science ®Google Scholar
• Weiss J, Hoffmann R, Rempp H, et al. Feasibility, efficacy, and safety of percutaneous MR-guided ablation of small (≤12 mm) hepatic malignancies. J Magn Reson Imaging. 2019;49(2):374–381.
   PubMed Web of Science ®Google Scholar
• Ku CY, Hyunchul R, Sik AY, et al. Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors. AJR Am J Roentgenol. 2006;186(5 Suppl):269–274.
   PubMed Web of Science ®Google Scholar
• Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology. 2000;217(2):558–563.
   PubMed Web of Science ®Google Scholar
• Lin Z-Y, Chen J, Deng X-F. Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation. Eur J Radiol. 2012;81(11):3079–3083.
   PubMed Web of Science ®Google Scholar
• Koda M, Tokunaga S, Miyoshi K, et al. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma. Eur J Radiol. 2012;81(10):2730–2736.
   PubMed Web of Science ®Google Scholar
• Stephan C, Hansj Rg R, Rüdiger H, et al. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance? Eur J Radiol. 2014;83(1):111–116.
   PubMed Web of Science ®Google Scholar
• Sandro R, Valentina R, Laura R, et al. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology. 2011;53(1):136–147.
   PubMed Web of Science ®Google Scholar
• Francica G, Saviano A, Sio ID, et al. Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients. Dig Liver Dis. 2013;45(4):336–341.
   PubMedGoogle Scholar